Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Nov 3, 2022Virtual Press Office and PR Newswire: General Trade show news
Annual User Conference Draws Attendees from the Hospital, Physician Advisor and Payer Spaces for Three Days of Experiential Learning NASHVILLE, Tenn., Nov. 3, 2022 /PRNewswire/ -- XSOLIS, the...
-
Nov 3, 2022Virtual Press Office and PR Newswire: General Trade show news
CTI BioPharma Corp. (Nasdaq: CTIC) today announced an oral presentation and two poster presentations from the Company's pacritinib program at the 64th American Society of Hematology (ASH®) Annual...
-
Nov 3, 2022Virtual Press Office and PR Newswire: General Trade show news
Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the acceptance of abstracts highlighting long-term clinical outcomes and impact on overall survival of AYVAKIT® (avapritinib) in...
-
Nov 3, 2022Virtual Press Office and PR Newswire: General Trade show news
-- ASH abstract contains previously presented data from June 2022 -- -- New clinical data from a recent data cut will be presented at ASH -- -- Company to host a live webcast event with an expert...
-
Nov 3, 2022Virtual Press Office and PR Newswire: General Trade show news
Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the...